Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Add-On Oral Bexarotene to Antipsychotic Treatment in Schizophrenia Patients: An Open Label Trial

NCT00141947 is registered in ClinicalTrials.gov with Beersheva Mental Health Center as lead sponsor.

NCT NCT00141947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00141947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Add-On Oral Bexarotene to Antipsychotic Treatment in Schizophrenia Patients: An Open Label Trial
Lead sponsor
Beersheva Mental Health Center
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2005
Completion date
September 30, 2006
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia